Inventor · disambiguated record
Anna M. Wu
Also filed as: WU ANNA · WU ANNA M
24 granted patents·11 pending applications·1,360 citations·filing 1992–2023
96Inventor score
Top patents by PatentIndex Score
35 records- 0198US5837821AAntibody constructHOPE CITY·Filed 1992·Granted Nov 17, 1998·471 cites·19 claims
- 0297US6410319B1CD20-specific redirected T cells and their use in cellular immunotherapy of CD20+ malignanciesHOPE CITY·Filed 1999·Granted Jun 25, 2002·719 cites·22 claims
- 0395US8404817B2Humanized anti-prostate stem cell antigen monoclonal antibodySHERMAN MARK A·Filed 2011·Granted Mar 26, 2013·43 cites·4 claims
- 0494US8940871B2Engineered anti-prostate stem cell antigen (PSCA) antibodies for cancer targetingWU ANNA M·Filed 2007·Granted Jan 27, 2015·39 cites·10 claims
- 0593US7776330B2Humanized anti-CEA T84.66 antibody and uses thereofHOPE CITY·Filed 2007·Granted Aug 17, 2010·25 cites·9 claims
- 0688US8940298B2High affinity anti-prostate stem cell antigen (PSCA) antibodies for cancer targeting and detectionWU ANNA M·Filed 2008·Granted Jan 27, 2015·13 cites·33 claims
- 0788US8088908B2Humanized anti-prostate stem cell antigen monoclonal antibodySHERMAN MARK A·Filed 2006·Granted Jan 3, 2012·10 cites·5 claims
- 0887US7273608B2Humanized anti-CEA T84.66 antibody and uses thereofHOPE CITY·Filed 2005·Granted Sep 25, 2007·10 cites·6 claims
- 0986US8043830B2Biotin-ligase system for secretion of biotinylated proteinUNIV CALIFORNIA·Filed 2009·Granted Oct 25, 2011·9 cites·15 claims
- 1086US7727525B2Engineered anti-CD20 antibody fragments for in vivo targeting and therapeuticsHOPE CITY·Filed 2007·Granted Jun 1, 2010·7 cites·5 claims
- 1181US9701754B1Covalent disulfide-linked diabodies and uses thereofWU ANNA M·Filed 2010·Granted Jul 11, 2017·2 cites·2 claims
- 1281US7939649B2Polynucleotide encoding luciferaseUNIV STANFORD·Filed 2006·Granted May 10, 2011·1 cites·14 claims
- 1380US8173791B2Luciferases and methods for making and using the sameGAMBHIR SANJIV S·Filed 2011·Granted May 8, 2012·1 cites·7 claims
- 1479US9765155B2Covalent disulfide-linked diabodies and uses thereofWU ANNA M·Filed 2012·Granted Sep 19, 2017·2 cites·1 claims
- 1579US8318906B2EMP2 antibodies and their therapeutic usesBRAUN JONATHAN·Filed 2008·Granted Nov 27, 2012·6 cites·15 claims
- 1677US8703920B2Fully human antibodies against N-cadherinREITER ROBERT E·Filed 2009·Granted Apr 22, 2014·2 cites·3 claims
- 1770US2024026025A1Humanized anti-n-cadherin antibodies and uses thereofUNIV CALIFORNIA·Filed 2023·Application pending·0 cites
- 1867US8378086B2Luciferases and methods for making and using the sameUNIV LELAND STANFORD JUNIOR·Filed 2012·Granted Feb 19, 2013·0 cites·7 claims
- 1966US8258277B2Luciferases and methods for making and using the sameGAMBHIR SANJIV S·Filed 2012·Granted Sep 4, 2012·0 cites·7 claims
- 2062US2018155449A1Covalent disulfide-linked diabodies and uses thereofHOPE CITY·Filed 2017·Application pending·0 cites
- 2159US9527919B2High affinity anti-prostate stem cell antigen (PSCA) antibodies for cancer targeting and detectionUNIV CALIFORNIA·Filed 2014·Granted Dec 27, 2016·0 cites·33 claims
- 2258US8785602B2EMP2 antibodies and methods of use thereof for causing regression of a solid tumor or symptoms thereofUNIV CALIFORNIA·Filed 2013·Granted Jul 22, 2014·0 cites·16 claims
- 2358US2015044694A1Engineered antibody-nanoparticle conjugatesUNIV CALIFORNIA·Filed 2014·Application pending·0 cites
- 2457US9011857B2Methods of treating cancer by administering EMP2 antibodiesUNIV CALIFORNIA·Filed 2012·Granted Apr 21, 2015·0 cites·6 claims
- 2557US8779104B2EMP2 antibodies and methods of use thereof causing regression of a solid tumor or symptoms thereofUNIV CALIFORNIA·Filed 2013·Granted Jul 15, 2014·0 cites·16 claims
- 2657US2020165351A1Humanized anti-n-cadherin antibodies and uses thereofUNIV CALIFORNIA·Filed 2018·Application pending·0 cites
- 2757US2010069616A1Engineered antibody-nanoparticle conjugatesUNIV CALIFORNIA·Filed 2009·Application pending·0 cites
- 2853US9624304B2Antibodies which bind to epithelial membrane protein 2 (EMP2)UNIV CALIFORNIA·Filed 2015·Granted Apr 18, 2017·0 cites·10 claims
- 2953US2023181772A1Engineered anti-prostate stem cell antigen fusion proteins and uses thereofHOPE CITY·Filed 2021·Application pending·0 cites
- 3052US2014017240A1Fully Human Antibodies Against N-CadherinUNIV CALIFORNIA·Filed 2013·Application pending·0 cites
- 3151US2012076728A1Human protein scaffold with controlled serum pharmacokineticsWU ANNA M·Filed 2010·Application pending·0 cites
- 3247US2016083450A1Human protein scaffold with controlled serum pharmacokineticsUNIV CALIFORNIA·Filed 2015·Application pending·0 cites
- 3346US10407503B2Fully human antibodies and fragments recognizing human c-MetUNIV CALIFORNIA·Filed 2013·Granted Sep 10, 2019·0 cites·38 claims
- 3445US2015191543A1Engineered antibody fragments for targeting and imaging cd8 expression in vivoUNIV CALIFORNIA·Filed 2013·Application pending·0 cites
- 3544US2008248463A1Split Enzyme Linked Immunosorbent and Nucleic Acid AssaysUNIV CALIFORNIA·Filed 2005·Application pending·0 cites
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →